Genetic ablation of CypA in ApoE KO mice has been shown to be anti-atherogenic [39], whereas pharmacological inhibition of CypA in ApoE KO mice promotes atherosclerosis [40]. This evidence concerns the gene PPIA and atherosclerosis.